ClinicalTrials.gov
public full text
Public Domain
Safety, Tolerability and Pharmacokinetics After Continuous Infusion of KAND567
The study was planned to consist of 24 healthy subjects in 3 dosing cohorts receiving a continuous i.v. infusion of KAND567 or placebo for 6 h (6 subjects on active and 2 subjects on placebo per cohort), with the option of two additional cohorts of the same size and group composition.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Hepatic Impairment on LDK378 Pharmacokinetics#875702
- TB006 Expanded Access (EA) Compassionate Use#841683
- Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF#915586
- A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight#890666
- A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet Formulations#877477
Record · ID 864175
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive